Abstract:Objective To investigate the clinical and biochemical profiles of the patients with lipid storage myopathy due to late onset glutaric aciduria type Ⅱ. Methods Seven patients (5 boys and 2 girls) with lipid storage myopathy due to glutaric aciduria type Ⅱ were reviewed. The diagnosis was confirmed by urinary organic acid analysis, blood free fatty acid assay with gas chromatography/mass spectrometry (GC/MS) and acylcarnitine profile by tandem mass spectrometry. Their clinical features, laboratory findings, and treatment were studied.Results These previous healthy patients began to develop progressive fatigue, proximal muscular weakness and pain from an age of 9 to 24 years. Five of them had poor appetite and body weight loss. Three had episodic palpitation. Three had recurrent lethargy. All patients had mild hepatomegly. Mild muscular weakness, hypotonia and absence of deep tendon reflexes were found in 4 of them. A marked elevation of serum CK, CK-MB, LDH, HBDH and a slight increase of lactate, pyruvate and β-OH-butyric acid were observed. A decrease of free carnitine was found in 7 patients. Three had hypoglycemia and ketosis. Mild metabolic acidosis and hyperammonemia were found in one boy. Muscle biopsy revealed lipid storage myopathy in all patients. Two of them had muscle fibers atrophy. Dried blood cis-4-decenoic acid (C10∶1), cis-4-tetradecenoic acid (C14∶1), middle chain and long chain acylcarnitine were significantly increased in all patients. An elevated excretion of 2-hydroxyglutaric acid, 3-hydroxyglutaric acid, 2-hydroxyisovaleric acid, and ethylmalonic acid in urine were confirmed in 4 patients. Ketotic dicarboxylic aciduria was found in 1 patient. All of the patients were responded to large dose of riboflavin (100～500 mg/d) significantly. Carnitine, coenzyme Q_(10) supplementation and protein-restricted diet were given for 1 to 2 months as a supporting therapy. Pronounced and rapid clinical and biochemical improvement was observed. All patients went back school or to work after 1 to 3 months therapy. Conclusions The late onset glutaric aciduria type Ⅱ is characterized by lipid storage myopathy. The adolescent patients might respond to riboflavin significantly. Early diagnosis and adequate therapy could contribute a lot to improve the prognosis of the patients. Urinary organic acid analysis and blood free fatty acid assay should be very helpful to the diagnosis.

Clinical and genetic features of three patients with non-classical isovaleric aciduria

[Clinical and Genetic Analyses of a Family with Atypical Nonketotic Hyperglycinemia Caused by Compound Heterozygous Mutations in the GLDC Gene].

Analysis of the genotype–phenotype correlation in isovaleric acidaemia: A case report of long-term follow-up of a chinese patient and literature review

Newborn screening for isovaleric acidemia: A case report of a Chinese patient with novel variants

[Genetic Analysis of Newborns with Abnormal Metabolism of 3-Hydroxyisovalerylcarnitine].

Leucodystrophy induced by late onset 3-hydroxy-3-methylglutaric aciduria

Organic acid profile of isovaleric acidemia: a comprehensive metabolomics approach

Eight novel mutations detected from eight Chinese patients with isovaleric acidemia.

Cinical treatment of 3-hydroxy-3-methylglutaric aciduria and a novel mutation on 3-hydroxy-3-methylglutaryl-coenzyme A lyase gene

[Clinical and Laboratory Studies on 28 Patients with Glutaric Aciduria Type 1].

Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency in Chinese Patients: Eight Case Reports, Including One Case of Prenatal Diagnosis

[Analysis of clinical features and genetic variants in three children with late-onset Multiple acyl-Coenzyme A dehydrogenase deficiency]

A Chinese girl with ethylmalonic encephalopathy and a novel mutation on ETHE1 gene

One Potential Hotspot ACADVL Mutation in Chinese Patients with Very-Long-chain Acyl-Coenzyme A Dehydrogenase Deficiency.

Two inborn errors of metabolism in a newborn: glutaric aciduria type I combined with isobutyrylglycinuria

Advances on the research of 3-hydroxy-3-methylglutaric aciduria

Isovaleric aciduria identified by newborn screening: Strategies to predict disease severity and stratify treatment

Clinical and Mutational Spectra of 23 Chinese Patients with Glutaric Aciduria Type 1.

Navigating the Diagnostic Journey in Pediatric Gastroenterology: Decoding Recurrent Vomiting and Epigastric Pain in a Child with Glutaric Aciduria Type II

Clinical and Biochemical Diagnostic and Therapeutic Survey of Seven Patients with Lipid Storage Myopathy Due to Glutaric Aciduria Type II

Clinical features and analysis of inherited metabolic diseases in neonatal intensive care unit